Atterocor debuts with $16 million
Newco Atterocor Inc. (Ann Arbor, Mich.) debuted on Friday with $16 million in a series A round led by Frazier Healthcare and 5AM Ventures. Atterocor is developing therapies to treat adrenal cancer. The company said it will provide details on its targ..
Original Article: Atterocor debuts with $16 millionNEXT ARTICLE